Robert Phillips
Rheumatology · Huntsville, ALNPI 1841218161
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 397 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 24.8% of the total. Reporting peaked in 2021 at $2,022 and has fallen 98.4% since, to $33 in 2023. That places this record below the midpoint for rheumatology clinicians in AL, where the typical reported total is $8,965.
Across 397 payments — averaging $16.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Amgen$1K
- Novartis$657
- Pfizer$334
- Johnson & Johnson$293
- GSK$267
- plus $2K from 21 others
What the payments were for
- Food & beverage$6,692100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 94 | $1,663 |
| Amgen(2 entities) | 88 | $1,318 |
| Novartis | 40 | $657 |
| Pfizer | 27 | $334 |
| Johnson & Johnson | 22 | $293 |
| GSK | 14 | $267 |
| E.r. Squibb & Sons, L.L.C. | 15 | $250 |
| Genentech USA, Inc. | 21 | $248 |
| Radius Health, Inc. | 13 | $190 |
| AstraZeneca(2 entities) | 6 | $177 |
| Janssen Scientific Affairs, LLC | 2 | $164 |
| Arbor Pharmaceuticals, Inc. | 3 | $155 |
| Aurinia Pharma U.S., Inc. | 6 | $148 |
| Boehringer Ingelheim | 6 | $137 |
| Mallinckrodt Hospital Products Inc. | 4 | $135 |
| Mallinckrodt Enterprises LLC | 5 | $123 |
| UCB, Inc. | 9 | $122 |
| Regeneron Healthcare Solutions, Inc. | 6 | $84 |
| Bristol Myers Squibb | 4 | $66 |
| Lilly USA, LLC | 3 | $43 |
| Medtronic | 3 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Assertio Therapeutics, Inc. | 1 | $17 |
| Merck | 1 | $13 |
| Tersera Therapeutics LLC | 1 | $13 |
| Antares Pharma, Inc. | 1 | $12 |
| Medexus Pharma, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,700 in reported general payments places this provider in the 45th percentile of 90 rheumatology providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SpsSodium Polystyrene Sulfon/Sorb | 11 | $3,431 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Huntsville
- William ShergyHuntsville$115K
- Kun ChenHuntsville$22K
- Deepak SreeHuntsville$17K
- Ayesha JaleelHuntsville$14K
- Margaret MeehanHuntsville$13K
- Christie ThomasHuntsville$12K
- Roxanna SabghiHuntsville$11K
- Elijah MitchamHuntsville$5K
- Anthony TurkiewiczMountain Brk$2.2M
- Jeffrey CurtisBirmingham$612K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.